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Abstract Mammalian xanthine oxidase (XO) and Des-
ulfovibrio gigas aldehyde oxidoreductase (AOR) are
members of the XO family of mononuclear molybdoen-
zymes that catalyse the oxidative hydroxylation of a wide
range of aldehydes and heterocyclic compounds. Much less
known is the XO ability to catalyse the nitrite reduction to
nitric oxide radical (NO). To assess the competence of other
XO family enzymes to catalyse the nitrite reduction and to
shed some light onto the molecular mechanism of this
reaction, we characterised the anaerobic XO- and AOR-
catalysed nitrite reduction. The identification of NO as the
reaction product was done with a NO-selective electrode
and by electron paramagnetic resonance (EPR) spectros-
copy. The steady-state kinetic characterisation corroborated
the XO-catalysed nitrite reduction and demonstrated, for the
first time, that the prokaryotic AOR does catalyse the nitrite
reduction to NO, in the presence of any electron donor to the
enzyme, substrate (aldehyde) or not (dithionite). Nitrite
binding and reduction was shown by EPR spectroscopy to
occur on a reduced molybdenum centre. A molecular
mechanism of AOR- and XO-catalysed nitrite reduction is
discussed, in which the higher oxidation states of molyb-
denum seem to be involved in oxygen-atom insertion,
whereas the lower oxidation states would favour oxygen-
atom abstraction. Our results define a new catalytic per-
formance for AOR—the nitrite reduction—and propose a
new class of molybdenum-containing nitrite reductases.
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Abbreviations
AOR Aldehyde oxidoreductase
DMSOR Dimethylsulfoxide reductase
EPR Electron paramagnetic resonance
Fe/S Iron–sulfur centre
Fe/S–NO Dinitrosyl–iron–sulfur complex
(MGD)2–Fe Ferrous complex of di(N-methyl-D-
glucamine dithiocarbamate)
(MGD)2–Fe–NO Mononitrosyl–iron complex
Mo-enzymes Pterin–molybdenum-containing
enzymes
NaR Nitrate reductases
NO Nitric oxide radical
SO Sulfite oxidase
XO Xanthine oxidase
Introduction
Molybdenum is present in a wide variety of enzymes, in
both prokaryotes and eukaryotes, where it performs cata-
lytic roles in important redox reactions of the carbon,
nitrogen and sulfur cycles [1–3]. Additionally, heterome-
tallic clusters of molybdenum are also found in other
proteins whose physiological function is not yet known
[4, 5].
With the exception of the unique iron–molybdenum
cofactor of the nitrogenase, molybdenum is found in
enzyme catalytic sites coordinated by the cis-dithiolene
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group of one or two pterin cofactor1 molecules (Scheme 1a)
[1–3]. The coordination sphere of the molybdenum atom is
completed with oxygen, sulfur or selenium atoms in a
diversity of arrangements (see below). In addition, these
pterin–molybdenum-containing enzymes (Mo-enzymes)
may contain other redox centres, such as flavins, haems
and iron–sulfur centres (Fe/S), which are involved in
the intramolecular and intermolecular electron transfer
processes.
According to the proposed structures of the molybde-
num centres, the Mo-enzymes have been divided into three
families [6]. The xanthine oxidase (XO) family has an
LMo=X (–OH/OH2) (=O) core, where L stands for the
pterin cofactor and X represents terminal =O, =S, or =Se
groups [7, 8]. This family comprises many enzymes with
diverse functions, such as aldehyde oxidoreductase (AOR)
from Desulfovibrio species, human XO and Eubacterium
barkeri nicotinate dehydrogenase. The CO dehydrogenase
from Oligotropha carboxidovorans, with its unique binu-
clear copper–molybdenum cofactor LMo–S–Cu–S–cys-
teine residue (–OH/OH2) (=O), is also included in the XO
family. The sulfite oxidase (SO) family, with an LMo–S–
cysteine residue (–OH/OH2) (=O) core, includes well-
known enzymes such as human SO and plant assimilatory
nitrate reductases (NaR, enzymes that catalyse the first and
rate-limiting step of nitrate assimilation in plants, algae and
fungi), but also the prokaryotic sulfite dehydrogenases [9].
The dimethylsulfoxide reductase (DMSOR) family has an
L2MoXY core, where X and Y represent terminal =O,
–OH, =S, and –SH groups and/or oxygen, sulfur or sele-
nium atoms from cysteine, selenocysteine, serine or
aspartate residue side chains [10]. This is a larger and more
diverse family, constituted by only prokaryotic enzymes
such as the DMSOR and formate dehydrogenase, as well as
dissimilatory NaR (periplasmic or membrane-associated
b 
a 
Scheme 1 The pterin cofactor structure (a) and the proposed
mechanism of XO-catalysed hydroxylation (b). a The pterin cofactor
is a pyranopterin-dithiolate moiety, which forms a five-membered
ene-1,2-dithiolate chelate ring with the molybdenum atom. In
eukaryotes, the pterin–molybdenum cofactor is found in the simplest
monophosphate form (R is one H atom). In prokaryotes, however, the
cofactor is found esterificated with several nucleotides: R could be
one cytidine monophosphate, one guanosine monophosphate or one
adenosine monophosphate. b The oxidised molybdenum (i) is coor-
dinated by one apical oxo group, two sulfur atoms of the pterin
cofactor (not represented), one hydroxide/water and one sulfido
group. For simplicity, the apical oxo group and the pterin sulfur atoms
were omitted from the reduced molybdenum coordination sphere (ii,
iii). The catalysis of hydroxylation is initiated by the activation of the
molybdenum-labile –OH/OH2 group by a neighbouring unprotonated
glutamate residue. The Mo6?–O- formed (i) makes a nucleophilic
attack on the substrate carbon atom (R–CH), with simultaneous
hydride transfer to Mo=S (ii). Subsequently, the product (R–CO-) is
displaced by a water molecule and a new –OH2 moiety reoccupies the
initial position (iii). The two electrons transferred from the substrate
to the molybdenum are then rapidly transferred to the FAD site, where
the reduction of molecular oxygen takes place
1 The pterin–molybdenum cofactor is still commonly referred to as
‘‘molybdopterin’’, because, historically, the cofactor was first iden-
tified in molybdenum-containing enzymes. However, the same
cofactor molecule is used to coordinate tungsten in some organisms
that are able to utilise that element. To avoid confusion between
molybdenum and tungsten-containing enzymes, the denomination
‘‘pterin–molybdenum cofactor’’, proposed by the Nomenclature
Committee of the International Union of Biochemistry (http://www.
chem.qmul.ac.uk/iubmb/etp/) was chosen.
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enzymes that function as respiratory oxidases) and assim-
ilatory NaR (cytoplasmatic enzymes), arsenite oxidase and
arsenate reductase. A fourth family was recently proposed
to include the pterin–tungsten cofactor-containing alde-
hyde:ferredoxin oxidoreductases (EC 1.2.7.5), found only
in archaea [11].
In general, the Mo-enzymes catalyse the transfer of an
oxygen atom from water to the product or from the substrate
to water, in reactions that imply a net exchange of two
electrons and in which the molybdenum cycles between
Mo6? and Mo4? [1–3]. It is based on this catalytic feature
that these Mo-enzymes are frequently referred to as ox-
otransferases (although there is at least one important
exception, the formate oxidation catalysed by the formate
dehydrogenase, Eq. 1). In particular, the enzymes of the XO
family catalyse the hydrolysis of a C–H bond with formation
of a C–O bond, in reactions of oxidative hydroxylation (e.g.
xanthine hydroxylation catalysed by XO, Eq. 2) [7, 8]. The
hydroxybenzoyl-CoA reductase is an important exception
within the XO family, as it catalyses the irreversible dehy-
droxylation (a reduction) of the phenol ring. The CO
dehydrogenase is another exception, since the CO2 forma-
tion from CO does not involve the hydrolysis of a C–H
bond. The members of the SO family, in contrast, catalyse
the simple transfer of an oxygen atom from or to a lone
electron pair of the substrate (e.g. nitrate reduction catalysed
by NaR, Eq. 3, or sulfite oxidation catalysed by SO, Eq. 4,
respectively) [9]. The DMSOR enzymes catalyse both the
cleavage of C–H bonds (e.g. formate oxidation, Eq. 1) and
the transfer of oxygen atoms (e.g. nitrate reduction, Eq. 3)
[10].
Formate oxidation (formate dehydrogenase oxidative
half-reaction):
HCOOH ! CO2 þ 2Hþ þ 2e ð1Þ
Xanthine hydroxylation2 (XO oxidative half-reaction):
RCH þ H2O ! RCOH þ 2Hþ þ 2e ð2Þ
Nitrate reduction (NaR reductive half-reaction):
NO2O
 þ 2Hþ þ 2e ! NO2 þ H2O ð3Þ
Sulfite oxidation (SO oxidative half-reaction):
SO23 þ H2O ! SO3O2 þ 2Hþ þ 2e ð4Þ
Mammalian XO (EC 1.17.3.2), the prototype of the XO
family, is a complex homodimer, with two different [2Fe–
2S] centres (named Fe/S I and Fe/S II) and one FAD,
besides the pterin–molybdenum cofactor [7, 8, 12]. The
molybdenum atom is present in a distorted square
pyramidal geometry, with one apical =O group and with
the four equatorial positions occupied by two sulfur atoms
of the cis-dithiolene (–S–C=C–S–) group of the pterin
cofactor molecule, one essential =S group and one labile –
OH/–OH2 group [13]. Physiologically, XO is a key enzyme
in purine catabolism, where it catalyses the hydroxylation
of both hypoxanthine and xanthine to the terminal
metabolite urate. However, it also catalyses the
hydroxylation of a wide variety of other nitrogen-
containing heterocyclic compounds and aldehydes, with
the simultaneous reduction of O2 [14].
The hydroxylation catalysis [15, 16] is initiated with the
activation of the molybdenum-labile –OH/OH2 group by a
neighbouring unprotonated glutamate residue (Glu-1261 in
the bovine enzyme) to form Mo6?–O- (base-assisted
catalysis) (Scheme 1b, i). The hydride transfer to the
essential =S group follows, with the simultaneous nucleo-
philic attack of the Mo–O- on the carbocation formed.
This concerted attack results in the formation of a covalent
intermediate, Mo4?–O–C–R (–SH) (Scheme 1b, ii). Sub-
sequently, the product (e.g. urate) is displaced by a water
molecule (Scheme 1b, ii ? iii) and a new –OH2 moiety
reoccupies the initial position to give Mo4?–OH2 (–SH)
(Scheme 1b, iii). The two electrons thus transferred from
the substrate to the molybdenum (Mo6? ? Mo4?, reduc-
tive half-reaction) are then rapidly distributed throughout
the Fe/S and FAD Scheme 1b, iii ? i), according to their
redox potentials. At the FAD site, the electrons are finally
transferred to O2 (oxidative half-reaction), to give O2
•- and
H2O2. The hydroxylations catalysed by the Mo-enzymes
are, therefore, quite different from those of the monooxy-
genases, as they generate (rather than consume) reducing
equivalents and use O2 as an oxidant and not as a source of
oxygen atoms (which in the Mo-enzymes case is water).
In addition to O2, XO can also catalyse the reduction of
several other compounds, including several sulfo- and nitro
compounds. In particular, the XO ability to catalyse the
nitrate reduction has long been known [17–19], but only
over the last years did this activity begin to be restudied
[20, 21]. The subsequent XO-catalysed reduction of nitrite
to nitric oxide radical (NO) has also been reported over the
last decade [20, 22–28], but it is not yet generally recog-
nised. Interestingly, the mammalian aldehyde oxidase [29],
another member of the XO family, was also recently shown
to catalyse the nitrite reduction to NO [28, 30]. This XO-
catalysed and aldehyde oxidase catalysed nitrite reduction
assumes particular importance owing to the amount of
experimental evidence that points towards the participation
of these two enzymes in the human in vivo formation of
NO from nitrite (as was extensively and recently reviewed
in [31–35]). However, in spite of these reactions being
known for a while, the molecular mechanism of nitrate and
nitrite reduction remains to be elucidated.
The main goal of this article is to study the molecular
mechanism of XO-catalysed nitrite reduction, to contribute2 Xanthine and uric acid represented in neutral form.
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to a better characterisation of this pathway of NO pro-
duction in humans. We also intended to assess the com-
petence of other XO family enzymes to catalyse this
reduction, to enlarge the sampling and variety of kinetic
and mechanistic data obtained. For this purpose, the AOR
(EC 1.2.99.7) from the sulfate-reducing bacterium Des-
ulfovibrio gigas was the family member chosen. This
enzyme possesses the same overall protein architecture,
with two [2Fe–2S] centres similar to the XO ones, although
it has no FAD [36]. AOR has the molybdenum atom in the
same square-pyramidal geometry as XO, but its pterin
cofactor is found esterificated with a cytidine monophos-
phate (pterin and cytosine dinucleotide) and it seems to
have an =O group instead of the essential =S group of XO
[37]. This enzyme catalyses the conversion of aldehydes to
the respective carboxylates at the molybdenum site, and the
Fe/S are involved in the intramolecular electron transfer to
an unknown physiological oxidising substrate, probably the
flavodoxin [38].
To accomplish those objectives, we kinetically charac-
terised the anaerobic XO- and AOR-catalysed nitrite
reduction. The identification of NO as the final reaction
product was done with an NO-selective electrode and by
electron paramagnetic resonance (EPR) spectroscopy. The
participation of the XO and AOR redox centres in nitrite
reduction was assessed by EPR spectroscopy, in the pres-
ence of typical reducing substrates (aldehydes, xanthine
and NADH), dithionite and site-specific inhibitors (allo-
purinol and ethylene glycol) and with samples of desulfo-
XO (an enzymatic form in which the essential Mo=S was
replaced by a Mo=O group). The kinetic and spectroscopic
results were integrated with the available structural and
mechanistic data [7, 12, 15, 16] to suggest a molecular
mechanism of molybdenum-dependent nitrite reduction.
Materials and methods
Materials
All the reagents were of the highest quality available and
were used as supplied. XO from bovine milk, xanthine,
NADH, benzaldehyde, 2,3-dihydroxybenzaldehyde, allo-
purinol, sodium nitrite, sodium dithionite, N-methyl-D-
glucamine dithiocarbamate, haemoglobin, 2,6-dichloroin-
dophenol (sodium salt) and uric acid (sodium salt), were
obtained from Sigma (Spain). All the other reagents were
from Merck (Darmstadt, Germany).
Enzyme samples
D. gigas AOR was purified as previously described [39] and
its concentration was determined spectrophotometrically
using an e of 24,600 M-1 cm-1 at 462 nm for the oxidised
(as-prepared) enzyme. The XO from bovine milk was
equilibrated in 50 mM phosphate buffer, pH 7.8, by gel
filtration on a small Sephadex G-25 column (GE Health-
care Bio-Sciences, Sweden), prior the assays. Desulfo-XO
was prepared by incubation with 10 mM KCN, in 50 mM
phosphate buffer, pH 7.8, for 30 min. After gel filtration
on a small Sephadex G-25 column, the desulfo-XO thus
prepared showed no xanthine:O2 oxidoreductase activity.
XO activity (xanthine:O2 oxidoreductase activity) was
measured in the presence of 20.0 lM xanthine, following
the formation of urate at 295 nm (De = 9,500 M-1 cm-1),
in air-equilibrated 50 mM phosphate buffer, pH 7.8. The
XO concentration was corrected for the presence of inac-
tive molecules assuming that 100% functional XO would
have an activity-to-flavin ratio of 200 [40]. The samples
used had an average activity-to-flavin ratio of 145. AOR
activity was assayed in the presence of 100 lM benzal-
dehyde, measuring the reduction of 75.0 lM 2,6-dichlo-
roindophenol, at 600 nm (e = 21,000 M-1 cm-1) in
50 mM phosphate buffer, pH 7.8. The activity assays were
recorded using a PC-linked UV/vis spectrophotometer
(Shimadzu UV-2101PC) in a temperature-controlled and
stirred cell. One unit of catalytic activity was defined as the
amount of enzyme required to catalyse the oxidation of
1 lmol of substrate per minute under our experimental
conditions.
NO measurements by spin-trapping
The reaction mixtures were prepared in an anaerobic
chamber (MBraun UniLab) and all the solutions were
first deoxygenated (argon-purged). The ferrous complex
of N-methyl-D-glucamine dithiocarbamate (MGD)2–Fe
was prepared by mixing ferrous ammonium sulfate and
N-methyl-D-glucamine dithiocarbamate to final concentra-
tions of 12.0 and 60.0 mM, respectively. The assays were
conducted at 293 K, in 50 mM phosphate buffer, pH 7.4,
containing 10.0–2.00 mM (MGD)2–Fe with the other
reactants concentrations as indicated in the figure legends.
Benzaldehyde and 2,3-dihydroxybenzaldehyde were the
aldehydes used with AOR and XO, respectively. The
reaction mixtures were then transferred to a quartz flat cell,
the cell was sealed and the EPR spectra at 293 K were
acquired as described below.
NO electrochemical measurements
Electrochemical measurements of NO were carried out
with an NO-selective Clark-type electrode (ISO-NOTM
Mark II, World Precision Instruments). The electrode was
calibrated daily with known concentrations of NO, gener-
ated with acidified nitrite solutions in the presence of
446 J Biol Inorg Chem (2011) 16:443–460
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potassium iodide, as described by the electrode manufac-
turer. The assays were carried out in 50 mM phosphate
buffer, pH 7.4, with the other reactant concentrations as
indicated in the figure legends, in a 1-cm3 anaerobic cell
and all the solutions were deoxygenated (argon-purged) for
20 min. Benzaldehyde and 2,3-dihydroxybenzaldehyde
were the aldehydes used with AOR and XO, respectively.
The reactions were initiated by adding the enzyme. The
steady-state apparent kinetic parameters were estimated by
the direct linear method of Eisenthal and Cornish-Bowden
[41] from the initial rates determined in at least three
independent experiments, varying the nitrite (1–200 mM)
and aldehyde (2.50–500 lM) concentrations.
Molecular mechanism of nitrite reduction probed
by EPR
The enzyme samples (150 lM) were incubated anaerobically,
at 293 K, with the reagent (substrate, dithionite, NO and
inhibitor) at the concentration and for the time mentioned
before being frozen. The spectra at 20 and 100 K were then
acquired as described in ‘‘EPR assays’’. The pure NO solution
(100 lM) was prepared by bubbling, for 30 min, 5% NO gas
in 50 mM phosphate buffer, pH 7.4 (through a 10% KOH
solution to remove other nitrogen oxides from the NO gas).
The NO concentration was calculated assuming a concentra-
tion of 1.9 mM for 100% NO gas, at 293 K.
EPR assays
X-band (9.65 GHz) EPR spectra were recorded using a
Bruker EMX 6/1 spectrometer. For 293 K spectra, an ER
4102ST cavity (Bruker) was used and the acquisition
conditions were a modulation frequency of 100 kHz,
modulation amplitude of 0.1 mT and microwave power of
20 mW. For low-temperature (20 and 100 K) spectra, an
ER4116DM rectangular cavity (Bruker) was used and the
samples were cooled with an Oxford Instruments ESR900
continuous-flow cryostat (with liquid helium), fitted with a
temperature controller. The acquisition conditions were a
modulation frequency of 100 kHz, modulation amplitude
of 0.5 mT and microwave power of 633 lW; the spectra
were acquired by sweeping the magnetic field between 325
and 375 mT, for the 20 K spectra, and between 335 and
360 mT, for the 100 K spectra.
Results
NO formation during XO-catalysed nitrite reduction
The identification of NO as the reaction product of nitrite
reduction was done with an NO-selective electrode and by
EPR spectroscopy. The first approach utilises a Clark-type
electrode (ISO-NOTM, World Precision Instruments) that is
selective for NO and the second one makes use of the spin-
trap (MGD)2–Fe. In the presence of (MGD)2–Fe, NO gives
rise to a mononitrosyl–iron complex (MGD)2–Fe–NO
which exhibits a characteristic EPR triplet signal at g of
2.04 with a hyperfine splitting of 1.27 mT [42].
An aldehyde (dihydroxybenzaldehyde) was the first
reducing substrate chosen to study the NO formation,
because it would allow a direct comparison between XO
and AOR. As shown by both methods (Figs. 1, 2, left
panels), XO-catalysed nitrite reduction to NO is dependent
on enzyme, aldehyde and nitrite concentrations and on
time. Moreover, the NO formation is absolutely dependent
on the simultaneous presence of enzyme, nitrite and alde-
hyde, as no NO formation was observed in the absence of
any of those three reactants (Figs. 1, spectrum c; 2, cur-
ves g–i). This NO generation was rapidly abolished upon
addition of haemoglobin (Fig. 2, curve f). Haemoglobin is
an effective scavenger of NO and this NO decay confirmed
that the observed curves do indeed reflect the NO forma-
tion. On the other hand, the fact that the NO formation was
also triggered by xanthine (which reacts at the molybde-
num centre) and NADH (which reacts at the flavin) (Fig. 2,
curves b, c), demonstrated that the NO formation is inde-
pendent of the nature of reducing substrate and of the reduc-
tion site. It is also worth mentioning that dithionite can also
promote the enzyme-dependent NO formation. Accordingly,
XO catalyses the nitrite reduction to NO in the presence of any
electron donor, substrate or not, reacting at any of the enzyme
redox centres. The results obtained agree quite well with
previously reported ones [23].
NO formation during nitrite reduction catalysed
by AOR
To evaluate the ability of other XO family enzymes to
catalyse the nitrite reduction, the AOR-catalysed NO for-
mation was measured by spin-trapping and with the NO-
selective electrode, with benzaldehyde as the reducing
substrate. AOR was found to catalyse the nitrite reduction
with NO formation in an enzyme-, aldehyde- and nitrite-
concentration-dependent manner. In the absence of AOR,
aldehyde or nitrite (Figs. 1, 2, right panels), no significant
NO formation was observed. In the presence of nitrite and
aldehyde, only after the addition of AOR was the NO
formation initiated (Figs. 1, spectra d, e; 2, curves j–l).
Again, dithionite can also promote the AOR-dependent NO
formation. However, the magnitude and the rate of NO
formation catalysed by AOR were lower than those
observed with XO. Taken together, these results showed
that AOR, in the presence of an electron donor (substrate or
not), does in fact catalyse the NO formation.
J Biol Inorg Chem (2011) 16:443–460 447
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magnetic field (mT)
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(c)  
magnetic field (mT)
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(c)  
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g=2.04 XO 
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Fig. 1 XO- and AOR-catalysed NO formation evaluated by EPR
spectroscopy with the spin-trap (MGD)2–Fe. XO (left panel) or AOR
(right panel) was anaerobically incubated with aldehyde and nitrite, in
50 mM phosphate buffer, pH 7.4, in the presence of 10.0–2.00 mM
(MGD)2–Fe, for 30 min, and the spectra of the (MGD)2–Fe–NO
complex formed were acquired as described in ‘‘EPR assays’’. The
reaction mixtures contained 117 nM (b) or 350 nM (a) XO with
400 lM dihydroxybenzaldehyde and 2.00 mM nitrite and 1.40 lM
(e) or 2.50 lM (d) AOR with 1.40 mM benzaldehyde and 1.70 mM
nitrite. The spectrum of a control assay (c), without enzyme, is also
shown
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Fig. 2 Time courses of XO- and AOR-catalysed NO formation
evaluated with the NO-selective electrode. Left: The anaerobic XO-
catalysed NO formation during nitrite reduction by aldehyde was
assayed in the presence of 2.5 mM (e) and 25 mM (a, d) nitrite and
50 lM (e) and 100 lM (a, d) dihydroxybenzaldehyde, with 0.33 lM
(d) or 1.00 lM (a, e) XO. To demonstrate the nitrite reduction in the
presence of other reducing substrates, NO formation was followed in
the presence of 25 mM nitrite and 1 mM NADH (b) or 50 lM
xanthine (c), with 75.0 nM (c) and 1.00 lM (b) XO. The effect on NO
formation of adding haemoglobin (?Hb) is illustrated in curve
e. Haemoglobin (100 lM) was added at the point indicated by the
arrow and the NO decrease was followed (f). Right: The anaerobic
AOR-catalysed NO formation during nitrite reduction by aldehyde
was assayed in the presence of 1.00 mM (l), 10.0 mM (k) and
200 mM (j) nitrite and 50 lM (k, l) and 500 lM (j) benzaldehyde,
with 1.00 lM (k, l) or 2.50 lM (j) AOR. In all cases, the reactions
were initiated by the addition of XO or AOR at the point indicated by
the arrow. Control curves performed in the absence of enzyme
(g) (with 25 mM nitrite and 250 lM aldehyde), aldehyde (with
25 mM nitrite and 1.00 lM XO (h) or AOR (m)) and nitrite (with
250 lM aldehyde and 1.00 lM XO (i) or AOR (n)) are also
represented
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Steady-state kinetics of nitrite reduction catalysed
by XO and AOR
The anaerobic nitrite reduction was, subsequently, kineti-
cally characterised, following the XO- and AOR-catalysed
NO formation, in the presence of dihydroxybenzaldehyde
and benzaldehyde as reducing substrates, respectively. The
initial rates of NO formation were determined with the NO-
selective electrode, as this method provides simple, con-
tinuous and direct measurements of the NO concentration as
a function of time. To kinetically characterise the nitrite
reduction, several assays were carried out, each at a different
fixed nitrite concentration (treated as a single-substrate
experiment), in which the apparent kinetic parameters were
determined after measuring the initial rate of NO formation
as a function of aldehyde concentration. For example, the
individual results observed in the presence of 1, 10 and
50 mM nitrite and 10 and 50 lM aldehyde are shown in
Fig. 3, and the calculated apparent kinetic parameters are
summarised in Table 1. Within the concentrations assayed,
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Fig. 3 Kinetics of NO formation catalysed by XO (diamonds) and
AOR (squares). The initial rates of NO formation were measured with
the NO-selective electrode, in 50 mM phosphate buffer, pH 7.4. a The
effect of aldehyde concentration on the initial rate of NO formation
during the reduction of nitrite at the concentrations indicated. b The
effect of nitrite concentration on the initial rate of NO formation
during the oxidation of aldehyde at the concentrations indicated.
Dihydroxybenzaldehyde and benzaldehyde were the aldehydes used
with XO and AOR, respectively. The hyperbolic curves shown were
generated with the apparent kinetic parameters given in Table 1
Table 1 AOR and XO kinetic parameters for NO formation during nitrite reduction in the presence of aldehyde
Apparent kinetic parameters
kcat
app aldehyde (s-1) Km
app aldehyde (lM) kcat
app nitrite (s-1) Km
app nitrite (mM)
AOR
Nitrite 1 mM 0.0748 59.0 Aldehyde 10 lM 0.0407 12.8
Nitrite 50 mM 0.105 11.7 Aldehyde 50 lM 0.0991 7.63
XO
Nitrite 1 mM 0.365 89.3 Aldehyde 10 lM 0.185 4.70
Nitrite 10 mM 0.645 37.3 Aldehyde 50 lM 0.461 2.29
Kinetic parameters
kcat (s
-1) Km aldehyde (lM) Km nitrite (mM) Ki aldehyde (lM)
XO 0.693 23.0 0.585 325 Ternary-complex mechanism
AOR 0.244 16.4 4.15 55.2
The initial rates of NO formation were measured with the NO-selective electrode, in 50 mM phosphate buffer, pH 7.4. Dihydroxybenzaldehyde
and benzaldehyde were the aldehydes used with XO and AOR, respectively. The apparent kinetic parameters for nitrite and aldehyde were
obtained in the presence of the substrate concentrations indicated. The real kinetic parameters were determined with the secondary plots shown in
Fig. 4c and d. For a ternary-complex mechanism, Ki
aldehyde is equivalent to Km for very low nitrite concentrations and is the true equilibrium
dissociation constant of the enzyme–aldehyde complex
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both AOR and XO reactions followed Michaelis–Menten
kinetics, with no evidence of substrate inhibition (no initial
rate decrease with increasing substrate concentrations). The
apparent kinetic parameters of XO are in good agreement
with those reported by Li et al. [23], in particular the value of
Km
app for nitrite (2.29 mM) that Li et al. found to be
2.4 ± 0.2 mM independently of the nature of the reducing
substrate (40 lM aldehyde, 5 lM xanthine or 1 mM
NADH).
Two primary plots for XO are represented in Fig. 4a and
b. A Lineweaver–Burk plot with no parallel lines and a
Hanes plot with lines that intersect at negative values
indicate that nitrite reduction follows a ternary-complex
mechanism, with Eq. 5 as the rate equation [41]. Since the
kinetic assays were conducted in the absence of added
products, it was not possible to determine if the binding of
substrates is ordered or random. However, it is plausible
that the aldehyde, like xanthine [43, 44], reacts only with
enzyme molecules with Mo6?. On the other hand, because
the EPR spectra (described later) did not give any evidence
for the nitrite interaction with Mo6?, it is probable that the
nitrite binds only to reduced molybdenum. Thus, it is
conceivable that the aldehyde is the first substrate to bind
(to the oxidised molybdenum), with nitrite binding second,
only after molybdenum reduction. Concerning the prod-
ucts, because both oxidation and reduction half-reactions
occur at the molybdenum centre (as described later), it seems
likely that the carboxylate must first leave the enzyme for
nitrite to be reduced. For these reasons, we suggest that the
nitrite reduction occurs through the formation of a ‘‘carbox-
ylate–enzyme–nitrite’’ complex, with the aldehyde being the
first substrate to bind and NO the last product to leave the
enzyme (a compulsory-order ternary-complex mechanism, as
schematically represented above Eq. 5).
 (5)
enzyme oxidised
aldehyde NO2 •- NOcarboxylate
carboxylate-enzyme-NO2-
ternary-complex 
enzyme oxidised
kcat [aldehyde] [nitrite] 
Ki aldehyde Kmnitrite  +  Kmnitrite [aldehyde]  +  Kmaldehyde [nitrite]  +  [aldehyde] [nitrite] 
v =  
The real kinetic parameters were determined with the
secondary plots shown in Fig. 4c and d [41]. The kinetic
parameters summarised in Table 1 describe the kinetics of
NO formation by both enzymes and allow a direct com-
parison between the two enzymes to be made. As expected
from the individual results (Figs. 2, 3), the specificity
constant of AOR for nitrite (0.0588 s-1 mM-1) was found
to be not as high as the XO constant (1.18 s-1 mM-1),
whereas the specificity constants for the aldehyde were
comparable (14.9 and 30.1 s-1 mM-1, respectively).
Nevertheless, as long as the nitrite concentration is high
enough, the rate of NO formation by AOR could attain
values similar to those of mammalian XO.
Participation of XO and AOR redox centres in nitrite
reduction
To gain insight into what happens in the XO and AOR
redox centres (molybdenum, Fe/S and FAD) during nitrite
reduction, the reactions with nitrite and NO were followed
by EPR spectroscopy.
First, the interaction of NO with the enzymes was
studied by adding pure NO (solution saturated with NO
gas) to XO and AOR samples reduced with aldehyde or
dithionite. The EPR spectra of those four samples showed,
besides the characteristic Mo5?-rapid type, Fe/S and
FADH• signals (the last one only in XO), one axial signal
at g\ = 2.04 and g// = 2.015 (data not shown). This axial
signal was attributed to a non-haem iron–dinitrosyl com-
plex, on the basis of the large amount of information
accumulated for over 50 years of extensive use of NO as a
spectroscopic probe for iron-containing proteins [45, 46].
In the case of XO and AOR, the axial signal must arise
from a dinitrosyl–Fe/S complex (Fe/S–NO), formed
through the reaction between NO and the reduced Fe/S.
The addition of NO to oxidised enzymes produced no
signals, until a reducer (aldehyde or dithionite) was added
and the Mo5?, Fe/S, Fe/S–NO and FADH• signals
appeared, demonstrating that the NO reacts only with
reduced Fe/S, as expected. Concerning the molybdenum
450 J Biol Inorg Chem (2011) 16:443–460
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and flavin, it should be noted that the NO treatment (either
before or after the reducer addition) caused no modification
of the Mo5? (a rapid type 1) and FADH• signals, even after
1 h incubation. In particular, it should be emphasised that
no conversion to a Mo5?-slow type signal was ever
observed. The slow signal arises from desulfo-XO mole-
cules (i.e. molecules in which the essential Mo=S was
replaced by a Mo=O group [47, 48]) and its absence
demonstrates that the added NO does not react with the
essential molybdenum sulfido group under our assay
conditions.
Once the reaction of NO with the enzymes redox
centres had been established, the nitrite reaction study
was initiated. First, the XO and AOR were reduced with
aldehyde, to develop the characteristic Fe/S (observed at
20 K), Mo5? and FADH• signals (observed at both 20 and
100 K) (Fig. 5, spectra a). After the addition of nitrite,
the intensity of all signals began to decrease (Fig. 5,
spectra b, c), as the enzymes became oxidised. Simulta-
neously, the NO formed started to bind to the reduced Fe/
S, and the axial signal characteristic of the Fe/S–NO
emerged. In fact, the presence of the Fe/S–NO signal is
additional proof that NO is being formed during the
nitrite reduction catalysed by XO and AOR. At this point,
the addition of more aldehyde led to the re-reduction of
the enzymes and to the reappearance of the Mo5?, Fe/S,
Fe/S–NO and FADH• signals (Fig. 5, spectra d). After
this second aldehyde addition, the Mo5?, Fe/S and
FADH• signals began to decrease once again, at the same
time as more nitrite was reduced (Fig. 5, spectra e). The
addition of nitrite to oxidised enzymes resulted in no EPR
signals, and only after the addition of aldehyde did the
signals begin to arise, suggesting that the nitrite does not
interact with oxidised enzymes. The same results were
obtained when the enzymes were reduced with xanthine,
NADH (only XO) or dithionite (both AOR and XO),
either before or after the nitrite addition (data not shown).
In all situations, the presence of nitrite never changed the
form of the Mo5?-rapid, Fe/S or FADH• signals and, once
more, the spectra obtained indicated that the NO enzy-
matically formed does not react with the essential
molybdenum sulfido group.
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Fig. 4 Kinetics of NO formation catalysed by XO. Lineweaver–Burk
(a) and Hanes (b) plots of the initial rates of XO-catalysed NO
formation, suggesting a ternary-complex reaction mechanism. The
secondary plots (according to Eq. 5) for the determination of the real
kinetic parameters presented in Table 1 are shown in c (r2 = 0.999)
and d (r2 = 0.987)
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The observed ‘‘redox cycles’’ (reduction ? oxida-
tion ? reduction…) indicate that all the AOR and XO
redox centres can participate in the electron delocalisa-
tion during catalysis, and that nitrite reacts only with
reduced enzymes. Nevertheless, none of the EPR spectra
provided direct evidence for the interaction of the nitrite
with the molybdenum, flavin or Fe/S, and the question of the
site of nitrite reduction prevailed. To answer that question, the
nitrite reduction was studied in the presence of two molybdenum
site-specific inhibitors (that do not interfere with the oxidation–
reduction of other redox centres), the allopurinol and ethylene
glycol.
Allopurinol (1H-pyrazolo[3,4-d]pyrimidine-4-ol), a struc-
tural isomer of hypoxanthine, is a potent XO inhibitor. XO
hydroxylates allopurinol to oxypurinol (1H-pyrazolo[3,4-
d]pyrimidine-4,6-diol), which binds tightly to the reduced
molybdenum, blocking it and inhibiting the XO hydroxy-
lase activity [40, 49, 50]. The formation of the oxypurinol–
XO complex, however, does not interfere with any reaction
occurring at the two Fe/S or at the FAD site, as shown by
the NADH oxidation by molecular oxygen (which occurs at
the flavin site) in the presence of the inhibitor [51].
Therefore, the Fe/S and FAD of allopurinol-inhibited XO
can be reduced with NADH, in spite of the molybdenum
being blocked. In view of that, if nitrite reduction occurs at
the Fe/S or flavin sites, then the NADH-reduced XO would
be able to reduce nitrite in the presence of allopurinol. To
test this hypothesis, the ability of allopurinol-inhibited XO
to catalyse the nitrite reduction was evaluated by EPR
spectroscopy. Allopurinol-reacted XO (Fig. 6, spectra a)
XO, 20K XO, 100K
(a)
(b)
(e)
(c)
(d)
g=2.04
g=2.02
g=2.04
g=2.02
(a)
(b)
(e)
(c)
(d)
325 340 355 370
magnetic field (mT)
340 345 350 355 360
magnetic field (mT)
AOR, 20K AOR, 100K
(a)
(b)
(e)
(c)
(d)
g=2.04
g=2.02
g=2.04
g=2.02
(a)
(b)
(e)
(c)
(d)
Fig. 5 XO-catalysed (top) and
AOR-catalysed (bottom) nitrite
reduction followed by EPR
spectroscopy at 20 K (left) and
100 K (right). XO and AOR
were first reduced with aldehyde
(enzyme/aldehyde 1:10, for
2–3 min (a)), to develop the
characteristic Fe/S, Mo5? and
FADH• signals (FADH• only in
XO). Nitrite was then added
(enzyme/nitrite 1:200) and
allowed to react for 1 min
(b) and 30 min (c), until the
enzymes became almost
completely oxidised. The
subsequent addition of more
aldehyde (enzyme/aldehyde
1:10, for 1 min (d)) led to the
reappearance of the Mo5?, Fe/S,
Fe/S–NO and FADH• signals.
The signals began to decrease
once again, at the same time as
nitrite was being reduced
(spectra e taken 30 min after the
aldehyde addition). The X-band
EPR spectra were acquired as
described in ‘‘EPR assays’’,
with a modulation amplitude of
0.5 mT and a microwave power
of 633 lW
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displayed the characteristic EPR signal [48] and, after
NADH addition, the FADH• and Fe/S signals emerged
(Fig. 6, spectra b), confirming that allopurinol-inhibited
XO can have its Fe/S and flavin reduced. The subsequent
addition of nitrite to inhibited XO, however, did not elicit
the enzyme oxidation or the Fe/S–NO formation (Fig. 6,
spectra c). To demonstrate that the Fe/S were not affected
by the presence of allopurinol, pure NO was added to a
sample of allopurinol-inhibited NADH-reduced XO,
resulting in the formation of the expected Fe/S–NO signal
(Fig. 6, spectra d). It should be noted that, under the same
conditions, the not inhibited (native) NADH-reduced
enzyme is promptly oxidised by nitrite, with Fe/S–NO
formation (Fig. 6, spectra e–g). In addition to the spec-
troscopic studies, the complete inhibition of NO forma-
tion by allopurinol was also demonstrated with the NO-
selective electrode, regardless of the reducing substrate
chosen (NADH, xanthine or aldehyde). These results
demonstrate that the XO-catalysed nitrite reduction is
dependent on the presence of an accessible (not blocked)
molybdenum centre.
The same reasoning was applied to determine the
AOR site of nitrite reduction, but because allopurinol
does not inhibit AOR, a spectroscopic study of the AOR
and XO ethylene glycol inhibition was undertaken.
Addition of ethylene glycol (1,2-ethanediol) gives rise
to a characteristic Mo5? rhombic signal that is resistant
to both oxidation and reduction [52, 53]. The signal is
thought to arise from a complex (where the inhibitor is
covalently bound to the molybdenum through two
oxygen atoms) that blocks the molybdenum atom,
without affecting the reduction of the Fe/S and flavin, in
a similar way as allopurinol does. The EPR spectra of
ethylene glycol treated dithionite-reduced AOR and XO
(not shown) exhibited the expected inhibited signal
along with the FADH• (only in XO) and Fe/S signals.
The subsequent addition of nitrite did not result in the
AOR or XO oxidation or in the formation of the Fe/S–
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(c)
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(d)
(g)
g=2.04
g=2.02
g=2.04
Fig. 6 Effect of allopurinol in XO-catalysed nitrite reduction probed
by EPR spectroscopy at 20 K (left) and 100 K (right)—comparison
with not inhibited enzyme. XO was first reacted with allopurinol
(enzyme/allopurinol 1:10, for 30 min) to develop the characteristic
inhibited signal (a). The enzyme was then further reduced with
NADH (enzyme/NADH 1:10, for 2–3 min) to give rise to the Fe/S
and FADH• signals (b). The inhibited reduced-XO was then mixed
with nitrite (enzyme/nitrite 1:200, for 30 min), but the resulting
spectra (c) were identical to the previous ones (apart from an increase
in the FADH• signal intensity), showing that the enzyme was not
oxidised by nitrite and that Fe/S–NO was not formed, in spite of the
Fe/S and flavin being reduced. When NO was added to a sample of
allopurinol-inhibited NADH-reduced XO, the spectra showed the
Fe/S–NO signal (d), confirming that, if NO was formed, it would give
rise to the Fe/S–NO signal. One tube of not inhibited (native) NADH-
reduced XO was treated alongside with the allopurinol-inhibited
sample. Apart from the Mo5?-rapid signal, the spectra of native
NADH-reduced XO (e) were similar to the allopurinol-inhibited
NADH-reduced XO ones (b). However, the native enzyme was
promptly oxidised by nitrite and the NO formed gave rise to the Fe/S–
NO signal (f). The addition of NO to native NADH-reduced XO also
resulted in the Fe/S–NO signal formation (g). The X-band EPR
spectra were acquired as described in ‘‘EPR assays’’, with a
modulation amplitude of 0.5 mT and a microwave power of 633 lW
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NO signal. Together, the allopurinol and ethylene gly-
col inhibition studies described prove that nitrite bind-
ing and reduction take place at the XO molybdenum
centre.
To investigate if the molybdenum sulfido group is
required for nitrite reduction, one sample of desulfo-XO
was prepared by reacting the native XO with cyanide, as
described in ‘‘Enzyme samples’’ [47, 48]. Whereas the
native sulfoenzyme promptly triggered the NO formation
in the presence of either aldehyde or NADH (Fig. 2), the
desulfo-XO was unable to catalyse the nitrite reduction,
with any reducing substrate (xanthine, aldehyde or
NADH, data not shown). The EPR spectra of the
NADH-reduced desulfo-XO displayed the characteristic
Fe/S and FADH• signals and the expected Mo5?-slow signal
(Fig. 7, spectra a). However, the addition of nitrite neither
oxidises the enzyme nor leads to the formation of Fe/S–NO
(Fig. 7, spectra b). The addition of pure NO to reduced des-
ulfo-XO resulted in the formation of the characteristic Fe/S–
NO signal (Fig. 7, spectra c), as expected. Under the same
conditions, the NADH-reduced sulfoenzyme was promptly
oxidised by nitrite, with Fe/S–NO formation (Fig. 7, spec-
tra d–f). The comparison of the results obtained with desulfo-
XO and sulfo-XO demonstrates that the molybdenum sulfido
group is necessary for the XO-catalysed nitrite reductase
activity.
A similar assay was attempted with an AOR sample.
However, after incubation with cyanide followed by gel
filtration, the AOR sample retained both the benzaldehyde
oxidase activity (as was observed and discussed in [25])
and nitrite reductase activity.
Discussion
AOR and XO-catalysed nitrite reduction to NO
The reduction of nitrate to nitrite by milk, in the presence
of aldehydes, was first described at the beginning of the
twentieth century, but only in 1924 did Dixon and Thurlow
[17] identify the milk component responsible for that
activity. Later, XO-catalysed nitrate reduction was further
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325 340 355 370
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20K 100K
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(b)
(e)
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(a)
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(e)
(c)
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(d)
Fig. 7 Effect of the XO molybdenum sulfido group in nitrite
reduction probed by EPR spectroscopy at 20 K (left) and 100 K
(right)—comparison between sulfo-XO and desulfo-XO. Native
(d) and desulfo-XO (a) were first reduced with NADH (enzyme/
NADH 1:10, for 30 min) to develop the characteristic Mo5?-rapid
(sulfo-XO) and Mo5?-slow (desulfo-XO) signals along with the Fe/S
and FADH• signals. Nitrite was then added (enzyme/nitrite 1:200, for
30 min), and, whereas the sulfo-XO was almost completely oxidised
(e), the desulfo-XO spectra obtained (b) were identical to the previous
ones (a), showing that the enzyme was not oxidised by nitrite and that
Fe/S–NO was not formed, in spite of the Fe/S and flavin being
reduced. When NO was added to a sample of NADH-reduced
desulfo-XO, the spectra showed the Fe/S–NO signal (c), confirming
that if NO was formed, it would give rise to the Fe/S–NO signal. The
addition of NO to NADH-reduced sulfo-XO also resulted in the Fe/S–
NO signal formation (f). The X-band EPR spectra were acquired as
described in ‘‘EPR assays’’, with a modulation amplitude of 0.5 mT
and a microwave power of 633 lW
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studied by a few groups [18, 19]. This activity was then
‘‘forgotten’’ until the late 1990s, when the (patho) physi-
ological importance of the generated NO was realised by
the groups of Blake, Harrison, Zweier and others [20–28]
who restudied the nitrate and nitrite reduction. The detailed
molecular mechanism of both reductions, however,
remains to be elucidated. Those works prompted us to
study the molecular mechanism of nitrite reduction and to
investigate if this nitrite reductase activity is common to
other enzymes of the XO family, namely to non-eukaryotic
enzymes.
The results presented in this work corroborated [22–28]
the mammalian XO-catalysed nitrite reduction and dem-
onstrated, for the first time, that the prokaryotic D. gigas
AOR does catalyse the nitrite reduction to NO in the
presence of an electron donor to the enzyme, substrate
(aldehyde) or not (dithionite) (Figs. 1, 2, 3). Providing that
the available nitrite concentration is high enough, the
steady-state kinetic characterisation (Table 1) showed that
the AOR can catalyse the NO formation at rates compa-
rable to the mammalian XO ones.
Site of nitrite reduction
Iron is the metal most prevalently used in nitrite reduction
(cd1 haem-dependent nitrite reductase, b-haem-containing
haemoglobin, myoglobin and neuroglobin, haem-contain-
ing cytochrome P450 and mitochondrial respiratory chain
cytochromes), whereas copper is found in the copper-
dependent nitrite reductases. It is also relevant to mention
that the specific endothelial NO synthase also reduces
nitrite to NO, in an anaerobic reaction that is b-haem-
dependent (like the oxygen-dependent L-arginine reaction)
[54].
Once the XO- and AOR-catalysed nitrite reduction had
been detected, it was mandatory to assign the metal
responsible for catalysis. The Fe/S could be candidates, but
nitrite reduction was shown by EPR spectroscopy to occur
at the molybdenum centre. The EPR spectra of reduced XO
and AOR showed that the native enzymes are promptly
oxidised by nitrite and that the NO thus formed reacts with
the reduced Fe/S to give rise to the characteristic Fe/S–NO
signal (Figs. 5, 6). Moreover, the primary source of
reducing equivalents to reduce the molybdenum had no
effect on the nitrite reduction, with any electron donor
(substrate or not) being able to promote the nitrite reduc-
tion (Figs. 2, 5, 6). Simultaneously, the EPR spectra of
ethylene glycol inhibited and allopurinol-inhibited (Fig. 6)
reduced XO and AOR revealed that, although the molyb-
denum, Fe/S and flavin centres were reduced, nitrite cannot
oxidise the inhibited enzymes and no NO is formed.
Together, these results prove unequivocally that the
molybdenum is the direct electron donor to nitrite, and that
nitrite binding and reduction is dependent on a ‘‘free’’
native reduced molybdenum centre.
Molecular mechanism of AOR- and XO-catalysed
nitrite reduction to NO
During XO-catalysed aldehyde oxidation3 by molecular
oxygen, one oxygen atom is transferred from water (the
oxo group donor) to the aldehyde (the reducing sub-
strate) to give the corresponding carboxylate (Eq. 6a), at
the molybdenum centre (Scheme 1b, i ? iii) [12, 15,
16]. The electrons thus introduced into the molybdenum
are subsequently transferred to the Fe/S and FAD. At the
flavin, the electrons are finally transferred to the
molecular oxygen (the oxidising substrate) (Eq. 6b).
During AOR catalysis, the same oxygen atom and
electrons transfer are thought to occur, in spite of the
fact that in this enzyme the electrons are transferred from
the Fe/S to a flavodoxin (the probable AOR oxidising
substrate [38]). Accordingly, during molecular oxygen or
flavodoxin reduction by an aldehyde, the XO or AOR
molybdenum centre participates only in the oxidative
half-reaction (Eq. 6a) of the overall catalytic cycle
(Eq. 6a, b).
During XO- and AOR-catalysed nitrite reduction by an
aldehyde, oxygen atom transfer must also take place, but
in this case the oxygen atom transfer must occur in both
directions. First, one oxygen atom is moved from the
water (or other oxo group donor) to the aldehyde
(Eq. 7a). After that, if NO is to be formed, another oxy-
gen atom has to be transferred from nitrite to an oxo
group acceptor, a water (Eq. 7b) or other molecule. In
addition, electron transfer must also occur from the
aldehyde (the reducing substrate) to nitrite (the oxidising
substrate, equivalent to molecular oxygen or flavodoxin)
(Eq. 7a, b). However, unlike the molecular oxygen or
flavodoxin reduction, the nitrite reduction occurs
unequivocally at the molybdenum centre. Furthermore,
the steady-state kinetic study carried out puts forward the
formation of a ternary complex, which is suggested to be
a ‘‘carboxylate–enzyme–nitrite’’ complex. Therefore,
during nitrite reduction by an aldehyde, the XO or AOR
molybdenum centre must participate directly in both the
oxidative and the reductive half-reactions (Eq. 7) of the
overall catalytic cycle.
3 Although the molecular mechanism of XO-catalysed hydroxylation
has been established for xanthine [7, 12, 15, 16], the underlying
mechanism of aldehyde hydroxylation [8] (or of other substrate that is
hydroxylated at the molybdenum site, such as FYX-051 [15]) is
thought to be essentially the same.
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xanthine or aldehyde oxidation4:
R-C-H + →
→
H2O  R-C-O- + 3H+ + 2e-  (a) 
(via Fe/S to FAD) (6) 
molecular oxygen reduction:
O2 + H+ + e-  nO2  + mH2O2   (b) .
xanthine or aldehyde oxidation4:
R-C-H + H2O  R-C-O- + 3H+ + 2e-   (a) 
 (both at the molybdenum centre) (7)
nitrite reduction:
NOO - + 2H+ + e- NO + H2O (b) 
→
→ •
nitrite reduction by an aldehyde:
ON2+H-C-R O- + H+  R-C-O- + 2 NO + H2O (8)→ .
In view of that mandatory bidirectional oxygen transfer,
which was established to occur at the molybdenum centre
through the formation of a ternary complex, we suggest
that the AOR- and XO-catalysed nitrite reduction by the
aldehyde (Eq. 8) follows the mechanism depicted in
Scheme 2. Accordingly, after molybdenum reduction by
the aldehyde (Scheme 2, A ? B), nitrite binds to the
reduced molybdenum, displacing the carboxylate through
the formation of a ternary ‘‘carboxylate–(Mo4?)–nitrite’’
complex (Scheme 2, C). Following nitrite reduction/
molybdenum oxidation, NO is released. Because nitrite
reduction is a one-electron process (Eq. 7b), the molyb-
denum would end up in a 5? oxidation state. The pKa of
the coordinated ligands change dramatically with the
molybdenum oxidation state, with the lower oxidation
states possessing highly protonated ligands [55, 56]. For
this reason, both the oxygen and the sulfur atoms are
depicted protonated, Mo5?–OH (–SH) (Scheme 2, E), in a
complex which would produce the characteristic Mo5?-
rapid type EPR signal with two interacting protons. To
generate a good leaving group (water, Mo5?–?OH2), the
consumption of one proton is suggested (Scheme 2,
E ? F, see also Eq. 8). Later, nitrite displaces the water
molecule (Scheme 2, G ? H) and, after a second cycle of
nitrite reduction/molybdenum oxidation, the second NO
molecule is released. The molybdenum is now in a 6?
oxidation state, which would favour the deprotonation of
its ligands [55, 56], and one proton is regenerated.
To account for the nitrite reduction by NADH or
dithionite, one additional branch was included in
Scheme 2, A ? I. Dithionite reduces both enzymes,
whereas NADH reduces only the XO, through the FAD
site, leading to molybdenum reduction through intramo-
lecular electron transfer [51]. Once the molybdenum is
reduced, Mo4?–OH2 (–SH) (Scheme 2, I), nitrite displaces
the water molecule (Scheme 2, J ? D) and the mechanism
of NO formation would follow as described above.
The kinetic data described herein point towards the
formation of a ternary complex, indicating that both sub-
strates must remain associated with the enzyme (Scheme 2,
C) before the first product is released. However, the car-
boxylate release before nitrite binding (Scheme 2, B ? I)
could represent an important pathway under assay condi-
tions different from ours, and for that reason it is also
depicted in Scheme 2. In any case, all three pathways
represented (A ? B?C ? D or A ? I?J ? D or
A ? B?I ? J?D) would lead to the formation of the
same Mo4?–ONO (–SH) intermediate (D). After the for-
mation of that nitrite–enzyme complex, the NO formation
would follow the same mechanism (D ? E?…A).
It should be noted that the mechanism described above
suggests that the oxygen atoms from the two nitrite mol-
ecules are transferred to one water (Scheme 2, D ? H)
and to one carboxylate molecule (Scheme 2, H ? A, see
also Eq. 8). That is, the nitrite is suggested to act not only
as an oxidising substrate, but also as an oxo group donor, a
role that is played by the water in the ‘‘classical’’ aldehyde
4 For simplicity, xanthine (pKa of 0.8 and 7.4) is represented in the
neutral form. Urate (pKa of 5.2 and 11.3) or carboxylate (pKa of 4.2
for benzoic acid) is depicted in the physiological monoanionic form.
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oxidation by molecular oxygen or flavodoxin (Scheme 1b,
ii ? iii). The water, on the other hand, is here suggested to
be an oxo group acceptor along with the aldehyde. Even
during nitrite reduction by NADH, the water should act as
an oxo acceptor (accepting one oxygen atom from each
nitrite molecule, Eq. 9):
nitrite reduction by NADH:
NADH þ 2NOO þ 3Hþ ! NADþ þ 2·NO þ 2H2O
ð9Þ
For the same reason, the Mo6? cores are proposed to act as
oxo group donors, whereas the Mo4? cores act as oxo group
acceptors, in a mechanism where the molybdenum
intermediates the oxygen atom transfer from one substrate to
the second substrate. This ‘‘double oxo transfer hypothesis’’,
initially proposed to account for reactions with molybdenum
model compounds [57–59], is supported by the chemical
uniqueness of molybdenum [60]. The Mo6?,5?,4? chemistry is
dominated by the formation of oxides and sulfides, but the
strong tendency of molybdenum to bind oxo groups is balanced
by its ability to lose a single oxygen atom easily [60], making
the molybdenum cores excellent ‘‘oxygen atom exchangers’’,
provided that the thermodynamics of the reactions is
favourable [61]. It is in the light of this molybdenum
versatile chemistry that the reaction of oxygen abstraction
from nitrite has to be thought.
The mechanism suggested does not dictate any obvious
catalytic role for the molybdenum sulfhydryl group
(Mo5?–SH or Mo4?–SH) in the nitrite reduction. However,
Scheme 2 Suggested mechanism of nitrite reduction by XO family
enzymes. For simplicity, the complete molybdenum coordination
sphere (omitting the pterin cofactor structure) is represented only for
oxidised enzyme (A). After molybdenum reduction by the aldehyde
(R–CH) (A ? B), nitrite binds to reduced molybdenum (C), displac-
ing the carboxylate (R–CO-) through the formation of a ternary
complex. Following nitrite reduction/molybdenum oxidation, NO is
released (D ? E). The resulting enzyme (E) would have the
molybdenum atom in a 5? oxidation state in a complex which
would produce the characteristic Mo5?-rapid type electron paramag-
netic resonance (EPR) signal with two interacting protons. To
generate a good leaving group (water), the consumption of one proton
is suggested (E ? F). Later, nitrite displaces the water molecule
(G ? H) and, after a second cycle of nitrite reduction/molybdenum
oxidation, the second NO molecule is released (H ? A). To account
for the nitrite reduction by NADH (only for XO) or dithionite (both
XO and aldehyde oxidoreductase (AOR)), one additional branch
(A ? I) was included (FAD only in XO). Once the molybdenum is
reduced (I), nitrite displaces the water molecule (J ? D) and the
mechanism of NO formation follows as described above. The
carboxylate release before nitrite binding (A ? B? I ? J) could
represent an important pathway under assay conditions different from
ours, and for that reason it was also depicted. R–CH stands for an
aldehyde or xanthine (in the neutral form), whereas R–CO-
represents the respective carboxylate or urate (both in the physiolog-
ical monoanionic form). Glu–C–OH (=O) represents the glutamate
residue thought to be responsible for the base-assisted catalysis
(residue 1261 in XO and residue 869 in AOR)
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its presence was shown to be crucial for the XO-catalysed
nitrite reduction (Fig. 7). A similar phenomenon is
observed in the XO inhibition by oxypurinol, where only
the reduced sulfo-XO molecules are inhibited, in a process
where the participation of the sulfhydryl group in the for-
mation of the Mo-oxypurinol complex is not presently
understood [40, 49, 50]. On the other hand, D. gigas AOR
apparently does not need the sulfido group to catalyse the
aldehyde oxidation [37] or the nitrite reduction. Under-
standing the role of the sulfido and oxo ligands during
molybdenum reduction and oxidation is, thus, of prime
importance in developing a deeper mechanistic insight into
the XO- and AOR-mediated catalysis.
Physiological relevance of the XO- and AOR-catalysed
nitrite reduction to NO
In mammals, NO is involved in several physiological
processes, such as vasodilatation and blood pressure reg-
ulation (through the well-known stimulation of guanylate
cyclase), inhibition of platelet aggregation, neurotrans-
mission, immune response, apoptosis, gene expression and
as a mediator in a wide range of both antitumour and
antimicrobial activities. Apart from those undoubtedly
beneficial effects, it can not be forgotten that the over-
production of reactive nitrogen species (NO itself, but
especially peroxynitrite) has been implicated in several
pathophysiological conditions, including chronic inflam-
matory conditions, septic shock syndrome, diabetes and
Parkinson’s and Alzheimer’s diseases. All of these reasons
made the NO formation the focus of huge interest by the
medical scientific community.
Under normoxia, NO is predominantly catalysed by NO
synthases and its biological effects are accomplished by
post-translational modification of transition metal centres
and cysteine residues [62]. To control the specificity of NO
signalling and to limit NO toxicity [63], NO synthase
activity is tightly regulated and the NO lifetime is con-
trolled through its rapid oxidation to nitrite and nitrate. In
fact, nitrate and nitrite had long been regarded as merely
inert end products of NO metabolism and of unfavourable
dietary constituents. However, this ‘‘dogma’’ has been
challenged by a growing number of independent studies
showing that nitrite, under hypoxia and anoxia, can be
reduced back to NO, in vitro, in situ and in vivo, and can
act as a vasodilator, as a modulator of mitochondrial res-
piration and as a cytoprotector during in vivo postischa-
emia injury in a wide range of tissues [31–35]. Nitrite
present in blood and other tissues has thus been viewed as
an NO storage form that could be made available under
conditions of hypoxia and anoxia to ensure cell survival.
The pathways of nitrite reduction to NO, extensively
reviewed recently [31–35], include non-enzymatic
disproportionation at low pH values, reduction by deoxy-
haemoglobin or myoglobin, by mitochondrial cytochromes
and cytochrome P450, and through the enzymatic conver-
sion by XO and aldehyde oxidase. The in vivo relative
importance of each of those ‘‘nitrite-recycling’’ pathways is
difficult to evaluate, because it is determined by multifac-
toral aspects: the molecular oxygen concentration, the
cellular pH and redox state, and the tissue type (which
determines the concentration of enzyme, nitrite and avail-
able reducing substrates). In the case of the XO-mediated
pathway, besides the concentration of nitrite (the limiting
substrate, given the millimolar Km value and the micro-
molar physiological nitrite concentration), the molecular
oxygen concentration present is particularly critical. Thus,
at the end of the enzyme reductive half-reaction
(Mo6? ? Mo4?), the electrons introduced into the
molybdenum site have two possible fates: (1) they could be
transferred directly to nitrite (as depicted in Scheme 2) or
(2) they could be intramolecularly distributed throughout
the molybdenum, Fe/S and flavin centres, according to the
redox potentials of the centres. It should be noted that the
reduction potentials of the XO centres are poised to favour
the molybdenum oxidation and the flavin reduction (with
the Fe/S acting as electrons ‘‘sinks’’), and that the intra-
molecular electron transfer is much more rapid than any of
the XO oxidation–reduction reactions [43]. So, if nitrite is
to be reduced, the electrons must remain in the molybde-
num centre. To accomplish that, a high concentration of the
reducing substrate (to maintain the enzyme fully reduced)
and a low concentration or absence of an additional oxi-
dising substrate are crucial. The concentration of the oxi-
dising substrate is particularly important in the case of
molecular oxygen, because its reduction is much faster
(with k = 35 s-1 for fully reduced enzyme [64]) than the
reduction of nitrite. In fact, molecular oxygen was found to
be a competitive inhibitor of the xanthine/XO-dependent
NO formation and more than 90% inhibition is observed in
aerobic conditions [25]. However, when NADH is the
reducing substrate, the XO-mediated NO formation is
maintained at more than 70% of the anaerobic levels [25].
This phenomenon is probably due to the binding of NADH
to the flavin, which blocks the access of the molecular
oxygen. So, NADH would be the major reducing substrate
for aerobic XO-catalysed NO formation; however, its high
Km (0.9 mM) and low kcat (0.2 s
-1 [23]) values question its
participation in the nitrite reduction. The cellular pH value
would also have an important effect on the competition
between nitrite and molecular oxygen, since low pH values
(as observed during ischaemia, pH 5.5–6.5) would con-
tribute to a faster nitrite reduction (data not shown and
[23]).
In conclusion, the XO-mediated NO formation would
depend on the competition between nitrite and molecular
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oxygen for the electrons provided by the reducing sub-
strates. Under hypoxia and anoxia (2–20 lM and less than
2 lM molecular oxygen, respectively), the resulting aci-
dosis and the increased concentrations of xanthine and
NADH will probably be sufficient to trigger the XO
‘‘nitrite-recycling’’ pathway. This prediction has actually
been confirmed by several in situ studies performed with
the XO-specific inhibitors allopurinol and oxypurinol [26–
28, 31, 65]. Under normoxic conditions, however, the XO
pathway would be almost certainly abolished.
In bacteria, the NO production has been thought to occur
only in the course of denitrification (reduction of nitrate to
dinitrogen), and NO has been seen simply as an interme-
diate of the anaerobic ‘‘nitrate respiration’’. However, there
is evidence that NO is involved in bacterial cell signalling
and in cytoprotection against oxidative stress [66]. In
addition, some bacterial and archaeal NO synthases,
homologous to the oxygenase domain of the eukaryotic
enzymes but lacking the reductase domain, were recently
described [67]. These NO synthases successfully reduce
arginine to NO, hijacking available cellular redox partners
that are not normally committed to NO production to
supply the required electrons. Together, those results show
clearly that bacterial NO is not a ‘‘useless’’ by-product.
D. gigas AOR was first described by Moura et al. [68]
and has been thought of as an aldehyde ‘‘scavenger’’, act-
ing in a complex chain of electron-transfer proteins that
links the oxidation of aldehydes to the reduction of protons
[69]. The AOR-dependent nitrite reductase activity
described herein could, therefore, constitute an alternative
pathway to produce NO directly from aldehydes. As dis-
cussed above, the in vivo relative relevance of this
‘‘recycling’’ pathway would be determined by the compe-
tition between nitrite and the available physiological oxi-
dising substrates. In AOR, Fe/S II is thought to be involved
in the intramolecular electron transfer to an unknown
physiological partner, probably flavodoxin [38], but not
molecular oxygen. Besides the concentration of nitrite,
which is again the limiting substrate (with an even higher
Km value of 4 mM), the cellular redox state would be of
critical importance, since it controls the redox state of the
protein partners of AOR.
Conclusions
The results described in the present work revealed a new
catalytic performance for AOR—the nitrite reductase
activity—and proposed a mechanism for the nitrite reduc-
tion catalysed by XO family enzymes. Given the XO and
AOR known reactions (oxygen insertion into xanthine or
aldehyde), the nitrite reduction (oxygen abstraction)
described herein may be seen as an unexpected reaction.
However, the molybdenum cores are well suited to promote
the oxygen atom transfer. The reactions observed for purine
catabolism (XO), aldehyde oxidation (AOR) and nitrite
reduction (XO and AOR) reflect different ways of atom
transfer: insertion (i.e. aldehyde ? carboxylic acid) and
abstraction (nitrite ? NO). In reality, these two types of
oxygen transfer are similar reactions, where the molybdenum
atom preferentially retains oxygen or promotes the oxygen
release. Higher oxidation states of molybdenum seem to be
involved in atom insertion, but lower oxidation states would
favour atom abstraction (Scheme 2). So this activity is prob-
ably common to other members of the XO family. For this
reason, we propose the existence of a new class of nitrite
reductases, molybdenum-dependent, that could significantly
amplify the biological capacity to produce NO.
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